IP Library › Granted Patent US 8,945,624
Granted Patent B2
US 8,945,624 · App. 12/185,023 · Granted Feb 3, 2015

Photoinitiated tissue filler

Inventors: Jennifer H. Elisseeff (Baltimore, MD); Alexander Hillel (Baltimore, MD); H. Janice Lee (Washington, DC)
Assignee: The Johns Hopkins University
A61Q19/00A61K8/02A61K8/8152A61L27/26A61L27/50A61K2800/81A61K2800/91
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,945,624
App. No.
12/185,023
Granted
Feb 3, 2015
Kind
B2
Abstract

Visible light-activated polymer cosmetic filler preparations useful in a variety of applications are provided. In some embodiments, the photo-activated polymer composition comprises a conventional polymeric material, such as HA, together with a modified, crosslinkable polymer, such as PEG or PEODA, to permit the formation of crosslinks within the polymer matrix in situ on exposure to a visible light source, such as an IPL device. The preparations provide for a more stabilized composition that is contourable during gelation.

Claims (12)

1. A method of filling a tissue space under the epidermis comprising:

a) introducing a polymer solution into the tissue space comprising:

i) a modified hyaluronic acid consisting of a Non Animal Stabilized Hyaluronic Acid having a molecular weight of about 1 million, and stabilized by 1,4-Butanediol Diglycidyl Ether (BDDE);

ii) PEGDA and/or PEODA having a molecular weight of between about 2000 to 3400 daltons;

iii) N-vinyl pyrrolidinone;

iv) at least one initiator;

wherein the ratio of PEGDA and/or PEODA to modified hyaluronic acid in w/w is from about 5:1 to 10:1; and

b) applying visible light to the surface of the epidermis superficial to said space to induce polymerization.

2. The method of claim 1 , wherein said visible light is provided by an IPL device.

3. The method of claim 2 , wherein said device is placed 1 cm above the epidermis.

4. The method of claim 2 , wherein said device is placed on the epidermis.

5. The method of claim 2 , wherein the PEGDA and/or PEODA has a molecular weight of about 3400.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 11, 2008
From: ELISSEEFF, JENNIFER H.; HILLEL, ALEXANDER; LEE, H. JANICE
To: JOHNS HOPKINS UNIVERSITY, THE
Reel/Frame 021818/0808 →
Continuity (2)
Provisional Application 60953375 · Aug 1, 2007
Related Publication 20090074868A1 · Mar 19, 2009